We did indeed observe regulation of several factors denoting endothelial dysfunction (CD31, VCAM, thrombospondin) and tissue remodeling (MMP9, chitinase 3‐like 1) in IMRT, but not in SABR patients. This evidence concerns the gene MMP9 and endothelial dysfunction.